- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Minnesota Becomes Fourth State to Lose Chief of Exchange
The director of Minnesota's health insurance exchange, April Todd-Malmlov, abruptly resigned this week, making the exchange the fourth state program to see a leadership change in the midst of mounting criticism over the rollout of President Obama's new health care law.
The director of Minnesota’s health insurance exchange, April Todd-Malmlov, abruptly resigned this week, making the exchange the fourth state program to see a leadership change in the midst of mounting criticism over the rollout of President Obama’s new health care law.
At a news conference on Wednesday, Ms. Todd-Malmlov’s successor was quick to promise fixes to problems still plaguing consumers, many of whom are worried about getting coverage by Jan. 1, when new policies under the law are set to take effect.
“There is no doubt that this process will improve moving forward,” said Scott Leitz, who was named the interim chief executive of MNsure, Minnesota’s state-run marketplace. “It will be a much better process than it is now, and it will be much easier to enroll.”
Read the full story here: http://bit.ly/18B80Pv
Source: The New York Times
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
